Morishita Jintan Co., Ltd.

4524.T
Drug Manufacturers - Specialty & Generic
2026/07/28 Updated
Market Cap: $55.1M (¥9.0B)
Stock Price: $13.44 (¥2,199)
Exchange Rate: 1 USD = ¥163.67

【Morishita Taizan】2024 Financial Results | Revenue Unknown (YoY Unknown)

The financial results for Morishita Taizan for April of Reiwa 8 have been finalized. While the details of revenue and net profit are unknown, revenue is unspecified, and net profit is unspecified. Reporting the parent company's financial results.

Importance:
Page Updated: July 28, 2026
IR Disclosure Date: July 28, 2026

Key Figures

  • Number of shares owned by the parent company, etc.: 160 thousand shares
  • Financial results finalization date: April 30, Reiwa 8
  • Capital stock: 8,000 thousand yen

AI要約

Financial Results Overview

The financial results for Morishita Taizan for April of Reiwa 8 have been finalized, and the financial details of the parent company are reported. The specific figures for revenue, operating income, and net profit are unknown, but the results have been officially announced upon finalization. The parent company's owned shares count 160 thousand shares, and details about shareholder composition and financial状況 have not been disclosed.

Future Outlook and Impact on Investors

While detailed financial results are unavailable, the finalization of the parent company's financial results serves as an indicator of the company's financial health and business strategy. Future earnings trends and stock price impact will depend on additional detailed information and upcoming earnings guidance. Investors should continue to monitor official announcements and future financial disclosures.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Morishita Taizan

Company overview · Stock price · Financial data · All IR

View company page →